Transgenomic Q3 Revenues Slip 3 Percent on Lower Lab Services Sales | GenomeWeb

NEW YORK (GenomeWeb) – Transgenomic announced after the close of the market today a three percent drop in its third quarter revenues, reflecting lower sales from its contract laboratory services as it continues to refocus on its ICE-COLD PCR molecular diagnostic offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.